hotspot -WSS

hotspot

author：focus 2025-09-14 21:54:53 - browse：99897

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Former Pear Therapeutics executives start new VC firm

leisure time

WSS

Can U.S. cancer drug shortages be fixed?

FDA advisory panel to debate high blood pressure devices

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Anthos stroke drug appears safer than common blood thinner

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Meadows told special counsel he could not recall Trump ever declassifying Mar

hotspot

hotspot

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why medical students are struggling with mental health

United colonoscopy coverage change 'may cost lives,' doctors say

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How to make over

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Bright Health sells Medicare Advantage business to Molina

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

entertainment

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Hospitals look to new technology to keep health care workers safe

Can U.S. cancer drug shortages be fixed?

DeSantis wants to import drugs. Biden’s FDA blasted his plan

NYU radiologists take on the challenge of expensive MRI machines

Gain of function research would be limited under House proposal

hotspot

hotspot

leisure time

focus